Cogent Biosciences (COGT) Accounts Payables: 2017-2020
Historic Accounts Payables for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $732,000.
- Cogent Biosciences' Accounts Payables rose 580.59% to $4.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.3 million, marking a year-over-year increase of 580.59%. This contributed to the annual value of $732,000 for FY2020, which is 77.00% down from last year.
- According to the latest figures from FY2020, Cogent Biosciences' Accounts Payables is $732,000, which was down 77.00% from $3.2 million recorded in FY2019.
- Over the past 5 years, Cogent Biosciences' Accounts Payables peaked at $3.2 million during FY2019, and registered a low of $732,000 during FY2020.
- For the 3-year period, Cogent Biosciences' Accounts Payables averaged around $1.8 million, with its median value being $1.5 million (2018).
- Per our database at Business Quant, Cogent Biosciences' Accounts Payables soared by 109.55% in 2019 and then slumped by 77.00% in 2020.
- Yearly analysis of 4 years shows Cogent Biosciences' Accounts Payables stood at $1.3 million in 2017, then increased by 12.85% to $1.5 million in 2018, then soared by 109.55% to $3.2 million in 2019, then slumped by 77.00% to $732,000 in 2020.